Common misconceptions

Common mistake
Wrong: Leukoplakia and oral candidiasis are distinguished only by appearance, not by whether the lesion can be scraped off.
Right: Oral candidiasis (thrush) produces white plaques that scrape off easily leaving an erythematous base, while leukoplakia cannot be scraped off and represents epithelial dysplasia.
The key bedside distinction is not appearance — both thrush and leukoplakia produce white lesions — it's scrapability. Oral candidiasis plaques wipe off with a tongue depressor and leave a raw, erythematous, sometimes bleeding base underneath. Leukoplakia is a white patch that is firmly adherent and represents epithelial dysplasia; it cannot be scraped off. If a vignette says the white lesion was easily removed, it's thrush. If it can't be removed and the patient has tobacco exposure, think leukoplakia and biopsy it.
Common mistake
Wrong: HPV-associated squamous cell carcinoma affects the oral cavity (lips, floor of mouth) like tobacco-related SCC.
Right: HPV-16-associated SCC arises in the oropharynx (tonsillar crypts, base of tongue), not the oral cavity proper.
HPV-16-associated SCC does not arise in the oral cavity proper — it arises in the oropharynx, specifically the tonsillar crypts and base of tongue, where the transformation zone of lymphoid tissue is vulnerable to HPV. Tobacco and alcohol drive cancers of the floor of mouth, ventral tongue, and lips. This distinction matters on USMLE Step 1 because the vignettes will differ: the HPV-related patient is often younger, a nonsmoker, and presents with a neck mass from a cystic tonsillar metastasis, while the tobacco/alcohol patient has a visible mucosal lesion with classic risk factors.
Common mistake
Gap: Underestimates oral lichen planus as a benign condition with no malignant potential
Oral lichen planus is a chronic inflammatory condition with a small but real risk of malignant transformation to SCC, requiring periodic surveillance.
Oral lichen planus is not purely benign — it carries a small but real risk (roughly 1-2%) of transformation to squamous cell carcinoma, particularly the erosive (ulcerative) subtype. This means patients need periodic follow-up and biopsy of any changing lesion, not just reassurance. Think of it like Barrett's esophagus conceptually: a chronic inflammatory/dysplastic process that warrants surveillance even though most patients won't develop cancer.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a clinical description of a white or ulcerated oral lesion, you must distinguish leukoplakia, oral candidiasis, oral lichen planus, and oral SCC based on appearance, location, scrapability, and patient risk factors.
  2. You must know when biopsy is indicated for an oral lesion — specifically, that leukoplakia, oral lichen planus, and any suspicious mucosal lesion require histologic evaluation to rule out dysplasia or carcinoma, not just watchful waiting.
  3. You must correctly link HPV-16 to oropharyngeal SCC (tonsillar crypts, base of tongue) and tobacco-alcohol synergy to oral cavity SCC (floor of mouth, ventral tongue, lip), and know that these differ in prognosis and demographics.

Can you avoid these mistakes?

A 45-year-old HIV-positive man has white plaques on his buccal mucosa. When examined, the plaques wipe off easily with a tongue depressor, revealing a red, raw base. What is the diagnosis, what organism is responsible, and how do you treat it?
A 60-year-old man with a 40-pack-year smoking history has a firm white patch on the floor of his mouth that cannot be scraped off. It has been present for 3 months. What is the next step in management, and what histologic finding would make you most concerned?
A 38-year-old nonsmoker, nondrinker presents with a 2-cm cystic neck mass. Imaging shows it originates near the right tonsil. Biopsy reveals squamous cell carcinoma. What virus is most likely responsible, which subtype, and how does this cancer's prognosis compare to tobacco-associated oral SCC?
A patient with oral lichen planus asks if they need any follow-up since their symptoms are controlled with topical steroids. What do you tell them, and which subtype of oral lichen planus carries the highest risk of malignant transformation?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →